Last mentioned: Mar 19, 2026
Cycle Completion
Target completion for the first 3-year development cycle under the new model.
First Milestone
Anticipated first-round validation of AI-modeled antidote candidates.
Bidding Window
Expected commencement of bidding for initial U.S. countermeasure contracts.
Consortium Launch
Lunai Bioworks officially announces the National Chemical Defense Consortium.
Consortium Launch
Lunai Bioworks officially establishes the National Chemical Defense Consortium.
Lunai Bioworks has established the National Chemical Defense Consortium to bid for U.S. government contracts valued between $400 million and $1.2 billion. The initiative leverages a proprietary three-year AI model designed to radically accelerate the development of antidotes against chemical threats.
Lunai Bioworks (NASDAQ: LNAI) has established the National Chemical Defense Consortium to secure up to $1.2 billion in U.S. government countermeasure contracts. The initiative centers on a proprietary three-year AI-driven model designed to accelerate the development of chemical antidotes.
Lunai Bioworks (NASDAQ: LNAI) has established the National Chemical Defense Consortium to target U.S. government countermeasure contracts valued up to $1.2 billion. The initiative leverages a proprietary three-year AI-driven development model to accelerate the creation of antidotes for chemical threats.
Lunai Bioworks (NASDAQ: LNAI) has established the National Chemical Defense Consortium to pursue up to $1.2 billion in U.S. defense countermeasure programs. The initiative utilizes a proprietary 3-year AI development model to drastically accelerate the creation of antidotes for chemical threats.